Alkermes (ALKS)
$45.34 -0.07% Close Oct 30, 2026 Live
Alkermes stock today
Alkermes closed at $45.34 on October 30, 2026, down 0.07% on the day. Over the past year it returned +47.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $7.56 billion.
$30.00$40.00$50.00
NovJan 2026MarMayJulSep
| Period | ALKS | S&P 500 (SPY) |
|---|---|---|
| 1 month | +11.9% | -0.9% |
| 3 months | -9.4% | +2.1% |
| Year to date | +62.0% | +11.7% |
| 1 year | +47.1% | +12.4% |
| 3 years | +86.5% | +88.5% |
| 5 years | +49.7% | +76.0% |
Key statistics
- Market value
- $7.56B
- P/E (trailing)
- 119.3
- Forward P/E
- 29.4
- Price / sales
- 4.5
- 52-week range
- $27.20 to $55.22
- Next report
- Nov 3, 2026
About Alkermes
Develops and markets pharmaceutical treatments for neurological and psychiatric conditions.
Sector: Health Care
More on Alkermes
- Financials: revenue, earnings and segmentsRevenue -5% in the year to Dec 2025
- Valuation: P/E history and peersP/E 119.3, median 13.3 at its last 3 year ends
- Returns: what $1,000 became$1,000 ten years ago is $888.85 today
No forecast, no recommendation. This page describes Alkermes from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.